Brad Ringeisen, PhD, serves as the Executive Director of the Innovative Genomics Institute (IGI), a cross-disciplinary organization dedicated to translating revolutionary gene editing tool development into affordable and accessible solutions for climate and health. Under his leadership, IGI has continued to advance new genome editing tools and push discoveries into real-world applications, supporting human clinical trials, agricultural field trials, and entrepreneurship.